PYC has competition, page-9

That has been my concern with the silence since november when the proprietry inhibitor was theoretically going to be announced. Before that it seemed to be all guns blazing, then in november instead of identifying lead option they announced they had multiple myc inhibitor options identified and much more scanning to do before a decision was made.

Ever since then even though we have had updates they have avoided actually addressing exactly where they are at with the lead candidate, never mind how they are now progressing with myc inhibition in blood cancer. It is starting to sound a little like we got the low hanging fruit but now its getting a bit difficult again. I know these things take time and i guess i f it wasnt for past history it would be easier to just let them stay quiet and get on with it. Unfortunately i dont want to wait until we run out of cash again to find out we hit another wall.